APA (7th ed.) Citation

U, C., H, M., P, T., K, I., P, T., S, S., . . . K, C. (2022). Quinazoline-based human phosphodiesterase 5 inhibitors exhibited a selective vasorelaxant effect on rat isolated pulmonary arteries involving NO-sGC-cGMP pathway and calcium inhibitory effects. Vascular pharmacology, 147, 107111. https://doi.org/10.1016/j.vph.2022.107111

Chicago Style (17th ed.) Citation

U, Chatturong, et al. "Quinazoline-based Human Phosphodiesterase 5 Inhibitors Exhibited a Selective Vasorelaxant Effect on Rat Isolated Pulmonary Arteries Involving NO-sGC-cGMP Pathway and Calcium Inhibitory Effects." Vascular Pharmacology 147 (2022): 107111. https://doi.org/10.1016/j.vph.2022.107111.

MLA (9th ed.) Citation

U, Chatturong, et al. "Quinazoline-based Human Phosphodiesterase 5 Inhibitors Exhibited a Selective Vasorelaxant Effect on Rat Isolated Pulmonary Arteries Involving NO-sGC-cGMP Pathway and Calcium Inhibitory Effects." Vascular Pharmacology, vol. 147, 2022, p. 107111, https://doi.org/10.1016/j.vph.2022.107111.